share_log

Bon Natural Life Limited Announces Major Breakthrough in Apple Polyphenol Technology, Set to Boost Fiscal 2024 Sales

Bon Natural Life Limited Announces Major Breakthrough in Apple Polyphenol Technology, Set to Boost Fiscal 2024 Sales

Bon Natural Life Limited宣佈蘋果多酚技術取得重大突破,將促進2024財年的銷售
GlobeNewswire ·  2023/12/12 09:00

XI'AN, China, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solution providers in the natural, health and personal care industries, today announced that the Company has achieved significant breakthrough in apple polyphenol extraction technology. This development is set to drive considerable growth in BON's apple polyphenol products in the upcoming fiscal year.

中國西安,2023年12月12日(GLOBE NEWSWIRE)——天然、健康和個人護理行業領先的生物原料解決方案提供商之一Bon Natural Life Limited(納斯達克股票代碼:BON)(“BON” 或 “公司”)今天宣佈,該公司在蘋果多酚提取技術方面取得了重大突破。這一發展將在下一財年推動BON蘋果多酚產品的顯著增長。

Apple polyphenol is a mixed natural compound that is widely used in dietary supplements and personal care products. However, due to the nature of its chemical instability, apple polyphenol's application and production always encounters technical difficulties and high production costs, which are deemed as one of the main impediments to the commercialization of apple polyphenols. After ten years of efforts in its R&D, with this pioneered technology, the Company is able to solve the quality stability problem and remove extra residues of the pesticide in the products, while significantly reducing costs.

蘋果多酚是一種混合天然化合物,廣泛用於膳食補充劑和個人護理產品中。但是,由於其化學不穩定性的性質,蘋果多酚的應用和生產總是遇到技術困難和高昂的生產成本,這被認爲是蘋果多酚商業化的主要障礙之一。經過十年的研發努力,憑藉這項開創性的技術,公司能夠解決質量穩定性問題,去除產品中農藥的多餘殘留物,同時顯著降低成本。

Mr. Yongwei Hu, Chairman and CEO of BON, commented: "We are proud to overcome the main commercialization barriers of apple polyphenol through technological innovation. Currently, our annual production capacity of apple polyphenol is approximately 300 to 500 tons. With the new technology breakthrough, we expect this product to make significant progress in dietary supplements and personal care products, where sales are expected to significantly increase with a trajectory of continued rapid growth. With its strong functionality and broad application range, we believe that the apple polyphenol segment will become be a key driver for our sustainable growth and a transformative force in the industry, significantly enhancing shareholder value for the company."

BON董事長兼首席執行官胡永偉先生評論說:“我們很自豪能夠通過技術創新克服蘋果多酚的主要商業化障礙。目前,我們的蘋果多酚年產能約爲300至500噸。隨着新技術的突破,我們預計該產品將在膳食補充劑和個人護理產品方面取得重大進展,預計其銷售額將大幅增長,並有持續快速增長的軌跡。憑藉其強大的功能和廣泛的應用範圍,我們相信蘋果多酚細分市場將成爲我們可持續增長的關鍵驅動力和行業變革力量,從而顯著提高公司的股東價值。”

About Bon Natural Life Limited

關於邦自然生命有限公司

The Company focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds for perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by their customers. For additional information, please visit the Company's website at .

該公司專注於生產個人護理原料,例如供香水和香水製造商使用的植物提取香精化合物,粉末飲料等天然健康補充劑以及客戶主要用作食品添加劑和營養補充劑的生物活性食品成分產品。欲了解更多信息,請訪問公司的網站 。

Safe Harbor Statement

安全港聲明

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend,""should,""believe,""expect,""anticipate,""project,""estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the natural, health and personal care market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

本新聞稿包含1995年《私人證券訴訟改革法》所定義的前瞻性陳述。前瞻性陳述包括與計劃、目標、目標、策略、未來事件或績效有關的陳述,以及基本假設和除歷史事實陳述以外的其他陳述。當公司使用諸如 “可能”、“將”、“打算”、“應該”、“相信”、“預期”、“預測”、“項目”、“估計” 或類似的表達方式時,它是在發表前瞻性陳述。前瞻性陳述不能保證未來的業績,涉及風險和不確定性,這些風險和不確定性可能導致實際業績與前瞻性陳述中討論的公司的預期存在重大差異。這些陳述存在不確定性和風險,包括但不限於以下內容:公司的目標和戰略;公司未來的業務發展;產品和服務的需求和接受程度;技術變化;經濟狀況;中國和公司計劃服務的其他國際市場的自然、健康和個人護理市場的增長;聲譽和品牌;競爭和定價的影響;政府法規;中國總體經濟和商業狀況的波動以及公司計劃服務的國際市場以及公司向美國證券交易委員會提交的報告中包含的上述任何風險和其他風險所依據或相關的假設。出於這些原因,除其他外,提醒投資者不要過分依賴本新聞稿中的任何前瞻性陳述。公司向美國證券交易委員會提交的文件中討論了其他因素,這些文件可在以下網址查看 www.sec.gov。公司沒有義務公開修改這些前瞻性陳述以反映本聲明發布之日之後發生的事件或情況。

For more information, please contact:
Bon Natural Life
Cindy Liu | IR
Email: bonnatural@appchem.cn

欲了解更多信息,請聯繫:
Bon 自然生活
Cindy Liu | 投資者關係
電子郵件:bonnatural@appchem.cn


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論